Skip to Content

Present Challenges and Opportunities in the New Era of Alzheimer’s Disease

Annie Cohen PHD is Associative Professor of Psychiatry at the University of Pittsburgh. This Podcast updates ongoing research and manifestation of Alzheimer’s Disease, its diagnosis (Amyloid, Tau deposition), biomarkers that may influence severity and early detection/diagnosis, also how social determinants of health affects early detection, e.g. access, extent of cardiovascular disease, residence, neighborhoods.

Release date: March 14, 2024

References:

  • Cohen AD. Distinct pathways for cognitive decline in the presence of Alzheimer's disease pathology or cerebrovascular disease. Brain. 2016 Sep;139(Pt 9):2340-1. doi: 10.1093/brain/aww183. PMID: 27559107.
  • Jia J, Ning Y, Chen M, Wang S, Yang H, Li F, Ding J, Li Y, Zhao B, Lyu J, Yang S, Yan X, Wang Y, Qin W, Wang Q, Li Y, Zhang J, Liang F, Liao Z, Wang S. Biomarker Changes during 20 Years Preceding Alzheimer's Disease. N Engl J Med. 2024 Feb 22;390(8):712-722. doi: 10.1056/NEJMoa2310168. PMID: 38381674.